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Introduction
A 34-year-old man with no significant past medical history was 
admitted to hospital on 16 February, with a three-day history of 
right lower quadrant pain, followed by nausea and vomiting. On 
physical examination, he appeared to be dehydrated (dry mucous 
membranes) with low-grade pyrexia [38°C, tachycardia (102 beats 
per minute)], mild abdominal distension, reduced bowel sounds and 
maximal tenderness at McBurneys’s point. 
Abdominal radiography revealed a small bowel dilatation and 
air fluid levels, and was followed by abdominal sonography 
suggesting features of a perforated appendicitis. The gut appeared 
to be aperistaltic, and the appendix was non-compressible and 
dilated (outer diameter of 10 mm), with free fluid in the abdomen. 
The patient was subsequently taken to theatre for an exploratory 
laparotomy on 17 February. During the operation, the appendix 
was found to be perforated and gangrenous, with four-quadrant 
peritoneal contamination and distended loops of small bowel. A large 
faecolith was noted at the appendiceal base. An appendectomy was 
performed, with extensive peritoneal washout and a pencil drain 
placed. The abdominal fascia was closed, and the skin left open to 
heal by secondary intention. While closing the abdomen, raised intra-
abdominal pressure was noted, and owing to concerns about the 
development of abdominal compartment syndrome, the patient was 
transferred to the intensive care unit (ICU).  
Anthropometry
The patient’s recumbent height was measured to be 165 cm, and 
his weight estimated to be 75 kg, with a body mass index (BMI) 
of 27.5kg/m2. This correlated well with his clinical appearance. 
His ideal body weight was calculated to be 68 kg (based on a BMI 
of 25 kg/m2).
Case report
On arrival in the ICU, the patient was intubated and placed on 
mechanical ventilation with fraction of inspired oxygen (FiO2) of 0.4. 
He was haemodynamically stable and did not require inotropic or 
vasopressor support. A laboratory evaluation revealed an elevated 
C-reactive protein (CRP) of 287 mg/l and hypoalbuminaemia of 
22 g/l. His blood glucose was well controlled at 6-8 mmol/l. On 
physical examination, the abdomen was distended and tender. 
Trans-bladder measurements revealed raised intra-abdominal 
pressure, ranging from 20-24 mmHg. He also presented with mild 
metabolic acidosis and a tapering urine output, which responded to 
fluids and furosemide. 
Immediate measures were taken to reduce the intra-abdominal 
pressure, and included: 
•	 Enteral decompression with a nasogastric tube.
•	 Initiation of prokinetic therapy to evacuate the intraluminal 
contents.
•	 Percutaneous catheter drainage to remove the intraperitoneal 
fluid collections.
•	 Diuretic therapy to remove excess fluid. 
The patient was kept nil per os (NPO) and received intravenous 
(IV) fluid therapy in the form of lactated Ringer’s solution. He was 
placed on a broad-spectrum antibiotic (amoxicillin plus clavulanate), 
antifungal (fluconazole), and received analgesic (morphine), 
antithrombotic (clexane) and ulcer prophylactic (ulsanic) therapy. 
On day 2, the patient was taken back to theatre for a relook laparo-
tomy since the laboratory analysis showed a dramatic rise in CRP 
(540 mg/l), together with persistently raised intra-abdominal 
pressure, ranging from 13-21 mmHg (normal range 5-7 mmHg in 
critically ill adults).1 During the laparotomy, a diagnosis of intra-
abdominal sepsis was made, and a pus specimen was sent for 
culture and sensitivity testing. The abdominal fascia was once 
again closed and the skin left open. Arriving back in ICU, the 
patient remained haemodynamically stable with a mean arterial 
pressure (MAP) of greater than 65 mmHg. Antibiotic therapy was 
escalated to tazocin (a combination of piperacillin and tazobactam), 
while awaiting the culture sensitivity results. The nasogastric tube 
was still on free drainage and had drained 300 ml over the past 
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24 hours. Furthermore, the patient presented with hypernatraemia 
(152 mmol/l). IV fluid therapy was changed to 5% dextrose water. 
At this point, the patient was referred to a dietitian for initiation 
of trickle feeding. An isotonic, fibre-free, semi-elemental feed 
was prescribed at a rate of 10 ml/hour. Prokinetic therapy in the 
form of erythromycin and metoclopramide was continued, and 
four-hourly gastric residual volumes measured. Culture sensitivity 
results confirmed the presence of Escherichia coli, bacteriodes and 
Klebsiella sensitive to carbapenems, a class of β-lactam antibiotics. 
Antibiotic therapy was subsequently escalated to ertapenem, a 
broad-spectrum carbapenem antibiotic. 
Over the next two days (days 3-4), the patient remained septic, a 
diagnosis based on pyrexia (>38.3°C), tachycardia (>90/min-1), 
tachypnoea (>20 beats per minute on continuous positive airway 
pressure (CPAP) ventilation), leucocytosis (white cell count 
>12 x 109/l), as well as an elevated creatinine (>44.2 µmol/l rise) 
and tapering urine output, the latter indicating severe sepsis with 
organ (renal) dysfunction.2 Despite persistently high intra-abdominal 
pressure in the range of 18-26 mmHg, there was no marked 
abdominal distension. 
Laboratory and blood gas analysis also showed a gradual decline 
in CRP, as well as an overall improvement in the acid-base status. 
A decision was made by the attending physician to continue 
nonoperative management and increase the feeding rate to 30 ml/
hour. However, enteral nutrition (EN) was discontinued a few hours 
later because of an acute episode of vomiting and a measured 
gastric residual volume of 280 ml. The patient was kept NPO for 
the rest of the day. On day 4, since the patient was normotensive 
with a gastric residual volume < 200 ml, and the abdomen was 
non-tender and soft, the multidisciplinary team decided to restart 
trickle feeding (combined with the prokinetic therapy previously 
prescribed), but refrained from increasing the feeding rate owing 
to the risk of gut ischaemia associated with enteral feeding in the 
midst of persistently raised intra-abdominal pressure. By day 5, the 
intra-abdominal pressure remained high (range 18-22 mmHg), and 
supplemental parenteral nutrition (PN) therapy was initiated in order 
to achieve adequate nutrient intake (Table I). An electrolyte-free PN 
regimen was ordered because of the presence of hypernatraemia. 
Additional glutamine supplementation was not considered because 
of the presence of severe sepsis with renal dysfunction. Since the 
dietitian was not on call over the weekend, clear notes regarding 
the feeding plan were recorded on the patient’s ICU chart. The 
plan was to increase the enteral feeding rate as soon as the intra-
abdominal pressure remained below 20 mmHg, given that the 
patient was haemodynamically stable and showed no other signs of 
feeding intolerance, i.e. a persistently high gastric residual volume, 
abdominal distension or vomiting.  
By Sunday (day 7), the measured intra-abdominal pressure was 
below 20 mmHg. Furthermore, the patient showed no signs of 
feeding intolerance and passed two soft stools. The EN formula 
was subsequently changed to a polymeric, isotonic, low-electrolyte 
formula, and titrated as per protocol to 70 ml/hour (25 kCal/kg, 1 g 
proteing/kg). PN was weaned accordingly, and stopped later on the 
same day. 
Early Monday morning (day 8 at 02h00), the patient developed a 
sudden onset of sepsis-induced hypotension with subsequent 
tissue hypoperfusion. This led to a further decline in renal function 
(acute oligouria and metabolic acidosis), as well as acute respiratory 
distress syndrome (ARDS) (PaO
2/FiO2 < 200). The patient’s pulse rate 
was 143 beats per minute, respiratory rate 42 (on CPAP ventilation), 
and his initial blood pressure 95/42 with a MAP of 60 mmHg. EN was 
discontinued owing to haemodynamic instability (MAP < 65 mmHg). 
Goal-directed, protocol-driven resuscitation was initiated, which 
included inotropic and vasopressor support, and the administration 
of boluses of lactated Ringer’s solution to increase the MAP to 
> 65 mmHg. By the time the dietitian assessed the patient (Monday 
at 08h00), he was awake and responsive, and maintained a MAP 
> 65 mmHg on a stable dose (0.11 µg/kg/minute) of adrenaline. 
However, he remained pyrexic (maximum temperature of 39.8°C, 
managed by active cooling) and because of several episodes 
of hyperglycaemia (> 10 mmol/l), was placed on a continuous 
insulin infusion to maintain his blood sugar level below 8 mmol/l. 
A laboratory evaluation showed a white cell count of 20.69 x 
109/l, blood urea nitrogen of 28.3 mmol/l, creatinine of 273 µmol/l, 
hypocalcaemia (1.96 mmol/l), severe hypernatraemia (162 mmol/l) 
and hyperchloraemia (132 mmol/l). IV fluid therapy in the form of 5% 
dextrose water (60 ml/hour), with additional sodium bicarbonate, was 
administered to improve renal perfusion and treat metabolic acidosis 
and hypernatraemia. EN was restarted (the same EN formula as that 
given the previous day), and increased as per protocol to 70 ml/hour, 
providing 25 kCal/kg (29 kCal/kg, including 5% dextrose water), 1 g 
protein/kg, and 420 mg Na/day. Measured gastric residual volume 
was < 200 ml throughout. 
By the next day (ICU day 9), the 
patient was anuric and required 
renal replacement therapy (RRT) 
in the form of sustained low-
efficiency dialysis (SLED). IV 
fluid therapy was stopped, and 
fluid intake derived from enteral 
feeds alone. The patient was still 
on a continuous insulin infusion 
for blood glucose control. 
Furthermore, he remained 
hypernatraemic (155 mmol/l), 
pyrexic (maximum temperature 









Protein (g) CHO (g) Lipids (g)







Trophic feed 10 240 198 11 34 7
PN regimen 60 1 144 891 63 
(10.6 g N/day)
95 47
5% dextrose water 60 288 288 0 72 -
Total 120 1 672 1 377 74 201 54
Total (per kg/day) 45** 25 20 1.1 3 0.8
CHO: carbohydrates, N: nitrogen, PN: parenteral nutrition
*: 1.2 g protein/kg. Protein was restricted to 1.2 g/kg because of the presence of renal dysfunction or acute kidney injury, and no dialysis
**: 45 ml/kg. Intravenous fluid challenge, together with diuretics, to improve urine output (acute kidney injury) 
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of 39.5˚C), and also developed severe diarrhoea of sudden onset. 
Prokinetic therapy was discontinued, and owing to concerns about 
possible Clostridium difficile infection, a stool sample was sent for 
C. difficile culture and C. difficile therapy (Flagyl®) was initiated 
empirically. A low-sodium and energy- and protein-dense feed was 
prescribed to allow adequate energy and protein provision at a fairly 
low rate of 45 ml/hour (Table II), given the presence of acute kidney 
injury (AKI) and fluid overload.
Table II details the patient’s feeding prescription on day 9.
The next day (ICU day 10), the patient’s septic condition was 
unchanged. A post-dialysis computed tomography (CT) scan of the 
abdomen ruled out the presence of intra-abdominal collections and 
nonoperative management was continued. Measured gastric residual 
volume remained < 200 ml, and there was a slight improvement in 
diarrhoea (C. difficile results pending). Furthermore, blood glucose 
control improved (< 8 mmol/l) with subsequent discontinuation of the 
continuous insulin infusion. The patient was kept on the same feeding 
prescription. In the early hours of the next morning, he required 
urgent RRT for sudden refractory hyperkalaemia (>7 mmol/l), but 
was considered to be too unstable for dialysis. The patient demised 
shortly thereafter, and post-mortem findings confirmed features of 
multi-organ failure with no intra-abdominal collections.
Discussion
Severe, life-threatening intra-abdominal infection, also known as 
peritonitis, is a frequent and dangerous entity in the ICU associated 
with increased morbidity, mortality and healthcare costs.3 According 
to Eckmann et al,4 one in four cases of severe sepsis or septic shock 
is caused by intra-abdominal infection. Almost 90% of all intra-
abdominal infection is so-called secondary peritoneal infection, 
i.e. contamination of the peritoneal cavity, in this case following 
a perforated appendicitis, and requires a surgical approach 
primarily, i.e. appendectomy and peritoneal washout. Furthermore, 
a perforated appendicitis is also a risk factor for the development 
of intra-abdominal hypertension and abdominal compartment 
syndrome, in severe cases.1 
Intra-abdominal pressure can be defined as the steady-state 
pressure within the abdominal cavity.1 Although various methods are 
available for its direct and indirect measurement, the gold standard 
is via a urinary bladder catheter.5 Although often measured in cmH2O, 
the recently updated consensus definitions and clinical practice 
guidelines from the World Society of the Abdominal Compartment 
Syndrome Society (WSACS), state that intra-abdominal pressure 
should be expressed in mmHg (1 mmHg = 1.36 cmH2O).
1 Intra-
abdominal pressure is approximately 5-7 mmHg in critically ill 
adults. Intra-abdominal hypertension can be defined as a sustained 
or repeated pathological elevation in intra-abdominal pressure 
> 12 mmHg.1 
Possible risk factors that may have contributed to elevated intra-
abdominal pressure in this patient included: 1
•	 Diminished abdominal wall compliance secondary to abdominal 
surgery. 
•	 Increased intraluminal contents secondary to possible 
postoperative ileus. 
•	 Increased intra-abdominal contents secondary to abdominal 
distension, intra-abdominal sepsis and/or intraperitoneal fluid 
collections. 
•	 Capillary leak secondary to the severe inflammatory response 
syndrome. 
•	 Others or miscellaneous, e.g. mechanical ventilation. 
On day 2, post relook laparotomy, EN was initiated in the form of a 
trickle feed. Trickle feeding, also known as trophic feeding, can be 
defined as a small amount of EN, typically prescribed at a rate of 
10-20 ml/hour, and administered primarily to maintain gut trophicity 
and mucosal barrier function, rather than serve as an energy 
supplement.6 Trophic feeding was considered for the following 
reasons in this particular patient. Firstly, the WSACS recommends 
that EN should be minimised in patients with intra-abdominal 
hypertension, since an increase in intraluminal contents may further 
increase intra-abdominal pressure.1 Secondly, intra-abdominal 
hypertension is often associated with gastrointestinal dysfunction. 
Raised intra-abdominal pressure causes a reduction in electrical 
and mechanical motor activity of the intestine and the inhibition 
of contractile responses, thereby leading to gut dysmotility.7 
Furthermore, the increased pressure within the abdominal cavity 
causes a reduction in splanchnic perfusion, with subsequent gut 
hypoperfusion.7 In turn, this may lead to bowel ischaemia, intestinal 
oedema, intramucosal acidosis, capillary leak and translocation of 
gut bacteria with further worsening of sepsis.5,7 The delivery of full 
EN, through increased mucosal oxygen requirements for nutrient 
absorption, may further increase the risk of the aforementioned 
complications.8 On the other hand, the administration of low-dose 
EN or trophic feeding places a reduced metabolic demand on the 
gut, and may also induce splanchnic vasodilation and improve gut 
perfusion, thereby reducing the risk of gut ischaemia.7,8 Moreover, 
trophic feeding has been shown to attenuate gut atrophy and 
improve host defences, thus limiting bacterial translocation.9,10  
Table II: Feeding prescription (day 9)
Rate (ml/hour) Total energy (kCal) Protein (g) CHO (g) Lipids (g) Sodium (mg)
Target (per kg/day) -  * 25 (up to 30**) 1.5 g/kg + 0.2 g/
kg***
40-50% NPE 50-60% NPE -
EN formula 45 1 620 108 133.92 72.36 513 (22 mmol)
Total (per kg/day) - 24 1.6 g/kg 45% NPE 55% NPE -
% of target - 96% 94% - - -
CHO: carbohydrates, NPE: non-protein energy; EN: enteral nutrition
*:  Fluid target: No fixed fluid target. Determined by attending physician and aimed at avoiding fluid overload, as well as dehydration during dialysis, fever and sepsis 
**: Fever further increases energy expenditure (10% increase for every 1°C > 37.5)
***: To compensate for increased losses via dialysate
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When initiating trophic feeds in a patient at risk of gut hypoperfusion, 
e.g. intra-abdominal hypertension, the choice of feed plays an 
important role. This is because the composition of the enteral 
formula affects the degree of splanchnic vasodilation and metabolic 
demand, with hyperosmolar and fibre-rich enteral formula resulting 
in significantly more stress on the gut’s absorptive capacity.11 
It has been proposed that hypertonic (> 700 mOsm) or fibre-rich 
enteral formula draws fluid into the gut, predisposing the patient 
to diminished gut perfusion, as well as dysmotility and subsequent 
small bowel overgrowth.6,8 Therefore, enteral formula with modest 
osmolality and minimal fibre may reduce the risk of complications 
relating to the feeding formula.8 According to the American Society 
for Parenteral and Enteral Nutrition, soluble and insoluble fibre 
should be avoided in patients at high risk of bowel ischaemia or 
severe dysmotility.12 Some studies even suggest that peptide-based 
formula may improve feeding tolerance through easier absorption 
across the gut lumen. Such formula may also improve nitrogen 
retention through increased visceral protein synthesis, as well as 
induce a trophic effect on the intestinal mucosa through increased 
glucagon synthesis.13 For the aforementioned reasons, trophic 
feeding was administered in the form of an isotonic, fibre-free, semi-
elemental formula in this patient. 
On day 3, EN was increased to 30 ml/hour, but discontinued a few 
hours later owing to an acute episode of vomiting and a measured 
gastric residual volume of 280 ml. Currently, there is insufficient 
scientific evidence or physiological grounds to establish a clear-cut 
threshold for a high gastric residual volume. According to Verburgh 
et al,14 gastric residual volume beyond 200 ml requires close 
monitoring. However, routine cessation of EN, solely on the basis 
of a gastric residual volume of 200-500 ml, should be avoided. EN 
was discontinued in this patient on the basis of a gastric residual 
volume > 200 ml despite prokinetic therapy, combined with an acute 
episode of vomiting and raised intra-abdominal pressure. Verburgh 
et al further recommend frequent challenges with small amounts 
of EN (evidence grade 2D) in patients with raised intra-abdominal 
pressure and/or consistent feeding intolerance, despite deliberate 
interventions taken to improve nutrient delivery, e.g. prokinetic 
therapy.14 For this reason, trophic feeding was restarted the next 
morning (postoperative day 4). Based on the patient’s pre-morbid 
nutritional status (BMI 27.5 kg/m2), supplemental PN was only initiated 
on postoperative day 5. Supplemental PN is widely recommended as 
a valuable tool for the prevention of a growing protein energy debt 
in the case of persistent EN intolerance.15 Nonetheless, the optimal 
timing of supplemental PN remains controversial, especially after 
the publication of recent trials,16-20 with conflicting results on the 
respective merits of early versus late initiation of supplemental PN. 
Although further research is needed before formal recommendations 
can be established, optimal timing seems to be somewhere between 
days 3 and 7, taking into consideration the severity of the illness, 
expected ICU length of stay and nutritional status.10,21-24  However, 
with combination feeding, daily monitoring is essential to avoid the 
potential risk of overfeeding.9 Furthermore, non-nutritional energy 
sources should be included in the total energy count to avoid 
overfeeding. For example, hypernatraemia and/or metabolic acidosis 
are often treated with the administration of 5% dextrose water (free 
water), and depending on the prescribed rate, can add considerably 
to total energy intake.25,26 Failure to do so may inevitably result in 
overfeeding, with further worsening of hyperglycaemia, as well as 
other potentially adverse effects, such as hypercapnoea, failure to 
wean from mechanical ventilation, azotaemia, immunosuppression, 
hypertriglyceridaemia and hepatic steatosis.10,15,27-29
Supplemental glutamine was not considered in this patient since 
glutamine should be avoided in ICU patients with multi-organ failure 
or shock, and should only be given to non-multi-organ failure patients 
receiving PN, based on the recently published REducing Deaths due 
to OXidative Stress (REDOXS) study by Heyland et al.10,30-32
From postoperative day 8 onwards, the patient required continuous 
inotropic and vasopressor support to maintain haemodynamic 
stability. Based on current evidence, vasopressors are not a 
contraindication to EN. Some studies even suggest that EN might 
benefit this type of patient subgroup through its ability to safely 
restore splanchnic perfusion and oxygenation.6,8 According to 
Heyland and Dhaliwal,33 the results of a large observational study 
of 1 174 critically ill patients on vasopressors revealed that early 
EN was associated with reduced hospital mortality, and that the 
beneficial effect of early EN was more pronounced in patients on 
Table III: Nutrition-related problems and considerations
Nutrition-related problems Considerations
Hypermetabolic and hypercatabolic state (severe sepsis, metabolic acidosis 
and fever)
Increased nutrient requirements 
Severe hypernatraemia Low electrolyte feed
Severe diarrhoea Soluble fibre
Partially hydrolysed/semi-elemental 
Hyperglycaemia Soluble fibre
High fat to carbohydrate ratio
Fluid overload Consider concentrated enteral nutrition formula to ensure adequate nutrient 
delivery despite fluid restriction.
AKI requiring RRT Compensate for increased protein and micronutrient losses via dialysate
Acute respiratory distress syndrome Consider enteral nutrition formula with a high fat to carbohydrate ratio and an 
anti-inflammatory profile
RRT: renal replacement therapy
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multiple vasopressor therapy. Therefore, the general consensus 
remains that EN can be safely administered in patients on stable or 
declining doses of vasopressors.6,12 
On postoperative day 9, the patient’s condition further deteriorated, 
and RRT in the form of SLED was initiated. Upon review of the 
patient’s feeding prescription, various factors were taken into 
consideration (Table III).
Severe hypernatraemia precluded the dietitian from prescribing a 
semi-elemental feed because of its high sodium content, which 
would otherwise be considered in a patient with concomitant 
hypoalbuminaemia and diarrhoea. The only option available was 
a low-sodium and energy- and protein-dense feed. This allowed 
the provision of adequate energy and protein at a fairly low rate of 
45 ml/hour, given the presence of AKI and fluid overload. Adequate 
nutrient provision is especially important in patients undergoing 
RRT, since together with the loss of vitamins and trace elements, an 
extensive amount of amino acids and protein may be lost through 
the extracorporeal circulation of RRT. On average, protein and amino 
acid losses, with the use of high-flux filtres and/or highly efficient 
modalities, such as SLED and continuous RRT, may be quantified 
as 0.2 g/kg of amino acid/litre of ultrafiltrate, amounting to 10- 
15 g amino acid/day, plus an additional 5-10 g/day of protein.34,35 The 
high fat to carbohydrate ratio of the feed may improve blood glucose 
control, and along with its anti-inflammatory profile (omega-3 fatty 
acids; eicosapentaenoic acid and docosahexaenoic acid), may play 
a supportive role in the management of ARDS. Despite the high fat 
content of this particular feed, the 100% soluble fibre may have 
assisted in binding the stools (grade C)12,14 and improving blood 
glucose control.36 Tap water can also be administered as an hourly 
flush, in addition to the enteral feed, to assist in the management of 
hypernatraemia, and possibly to provide relief from the diarrhoea 
through the dilution of the concentrated enteral formula. 
Conclusion
This case presentation reflects the dynamicity of critical illness and 
the importance of daily monitoring to ensure appropriate adjustment 
of feeding goals to meet constantly changing metabolic demands. 
Furthermore, it also highlights several controversial issues with 
regard to nutrient delivery in the ICU, i.e. the role of trophic feeding, 
optimal timing with regard to the initiation of supplemental PN, as 
well as glutamine administration in the critical care setting. 
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